TABLE 47Consultant and non-consultant cost of clinical examinations

Surveillance intervalRegimenICER at low and high clinical examination cost (£):
6586
12 monthsNo surveillance
Mammography alone49454727
Mammography + clinical178,716236,826
MRI + clinical297,829297,848
18 monthsNo surveillance
Mammography alone40573811
Mammography + clinical89,362118,455
MRI + clinical142,296142,331
24 monthsNo surveillance
Mammography alone36443366
Mammography + clinical59,00278,167
MRI + clinical90,33990,382
36 monthsNo surveillance
Mammography alone34103099
Mammography + clinical45,04359,607
MRI + clinical66,74166,789

From: 7, Economic evaluation

Cover of The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation
The Clinical Effectiveness and Cost-Effectiveness of Different Surveillance Mammography Regimens After the Treatment for Primary Breast Cancer: Systematic Reviews, Registry Database Analyses and Economic Evaluation.
Health Technology Assessment, No. 15.34.
Robertson C, Arcot Ragupathy SK, Boachie C, et al.
Southampton (UK): NIHR Journals Library; 2011 Sep.
© 2011, Crown Copyright.

Included under terms of UK Non-commercial Government License.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.